© 2021 MJH Life Sciences and HCPLive - Clinical news for connected physicians. All rights reserved.
© 2021 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
June 10, 2021
Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, share their approach to selecting PAMORAs in clinical practice for the optimal management of opioid-induced constipation.
A discussion on the use of oral methylnaltrexone for the treatment of opioid-induced constipation in patients with chronic non-cancer pain and the implications for clinical practice.
June 03, 2021
Gerald Sacks, MD, and Fariborz Rezai, MD, FCCP FCCM, review the diagnosis of opioid-induced constipation and goals of treatment.
Gerald Sacks, MD, discusses the pathophysiology of opioid-induced constipation (OIC) and provides insight on common medical conditions that often lead to OIC.